TrialArthritis care & research2026

Effectiveness and Safety of Baricitinib for Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis.

Athimalaipet V Ramanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.